Published in Stroke on July 01, 1997
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol (2010) 1.91
Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol (2014) 1.86
Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective. Eur J Pharmacol (2008) 1.82
Adiposity, type 2 diabetes, and Alzheimer's disease. J Alzheimers Dis (2009) 1.53
Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke (2013) 1.51
Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke. J Heart Lung Transplant (2014) 1.48
Middle cerebral artery occlusion model in rodents: methods and potential pitfalls. J Biomed Biotechnol (2011) 1.46
MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients. Eur Radiol (2008) 1.32
Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis (2012) 1.28
Clinical study of 99 patients with pure sensory stroke. J Neurol (2005) 1.25
Adiposity and Alzheimer's disease. Curr Opin Clin Nutr Metab Care (2009) 1.17
No difference in stroke knowledge between Korean adherents to traditional and western medicine - the AGE study: an epidemiological study. BMC Public Health (2006) 1.10
Perceptions of risk: understanding cardiovascular disease. Risk Manag Healthc Policy (2010) 1.01
Type 2 diabetes and late-onset Alzheimer's disease. Dement Geriatr Cogn Disord (2011) 0.99
Comparison of carotid endarterectomy and stenting in real world practice using a regional quality improvement registry. J Vasc Surg (2012) 0.98
Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients. Clin Infect Dis (2012) 0.98
Improved diabetes control in the elderly delays global cognitive decline. J Nutr Health Aging (2011) 0.98
Joint effects of risk factors for stroke and transient ischemic attack in a German population: the EPIC Potsdam Study. J Neurol (2007) 0.97
Blood microRNAs in low or no risk ischemic stroke patients. Int J Mol Sci (2013) 0.95
Vascular risk factors in the Swiss population. J Neurol (2005) 0.95
Machine learning for outcome prediction of acute ischemic stroke post intra-arterial therapy. PLoS One (2014) 0.94
Adiposity and Alzheimer's disease. Curr Alzheimer Res (2007) 0.92
Vascular risk and depression in the Hispanic Established Population for the Epidemiologic Study of the Elderly (EPESE). Int J Geriatr Psychiatry (2009) 0.92
Risk factor management to prevent first stroke. Neurol Clin (2008) 0.92
Chiropractic care and the risk of vertebrobasilar stroke: results of a case-control study in U.S. commercial and Medicare Advantage populations. Chiropr Man Therap (2015) 0.90
Ten year recurrence after first ever stroke in a Japanese community: the Hisayama study. J Neurol Neurosurg Psychiatry (2005) 0.89
Hydrogen saline offers neuroprotection by reducing oxidative stress in a focal cerebral ischemia-reperfusion rat model. Med Gas Res (2011) 0.88
Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer? Circulation (2007) 0.87
Perceived access to health care and its influence on the prevalence of behavioral risks among urban African Americans. J Natl Med Assoc (2002) 0.86
Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke. Int J Mol Sci (2013) 0.86
Pretreatment with a single estradiol-17beta bolus activates cyclic-AMP response element binding protein and protects CA1 neurons against global cerebral ischemia. Neuroscience (2009) 0.86
Alzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase. CNS Neurol Disord Drug Targets (2012) 0.85
Low HDL-C level is associated with the development of intracranial artery stenosis: analysis from the Chinese IntraCranial AtheroSclerosis (CICAS) study. PLoS One (2013) 0.85
Hyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifen. Br J Pharmacol (2003) 0.84
Low bone mass is associated with carotid atherosclerosis in postmenopausal women: the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int (2008) 0.84
Antiplatelet therapy in populations at high risk of atherothrombosis. J Natl Med Assoc (2006) 0.84
Young stroke mortality in fiji islands: an economic analysis of national human capital resource loss. ISRN Neurol (2012) 0.84
Exercise increases endostatin in circulation of healthy volunteers. BMC Physiol (2004) 0.84
Neuroimaging of cerebrovascular disease in the aging brain. Aging Dis (2012) 0.83
Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NF-κB pathway. J Cell Mol Med (2010) 0.83
What are the Risk Factors for Cerebrovascular Accidents After Elective Orthopaedic Surgery? Clin Orthop Relat Res (2015) 0.83
A randomized trial testing the superiority of a postdischarge care management model for stroke survivors. J Stroke Cerebrovasc Dis (2009) 0.82
The reliability of repeated TMS measures in older adults and in patients with subacute and chronic stroke. Front Cell Neurosci (2015) 0.81
Association of genetic variants with hypertension in a longitudinal population-based genetic epidemiological study. Int J Mol Med (2015) 0.81
The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke. Neurotherapeutics (2016) 0.81
The 2006 William Feinberg lecture: shifting the paradigm from stroke to global vascular risk estimation. Stroke (2007) 0.81
Association of genetic variants of the α-kinase 1 gene with type 2 diabetes mellitus in a longitudinal population-based genetic epidemiological study. Biomed Rep (2015) 0.80
Dairy consumption and stroke risk. Int J Prev Med (2013) 0.80
The impact of age on cerebral perfusion, oxygenation and metabolism during exercise in humans. J Physiol (2015) 0.79
Does vitamin D deficiency contribute to erectile dysfunction? Dermatoendocrinol (2012) 0.79
Risk factors and 30-day case fatality of first-ever stroke in Basrah, Iraq. Niger Med J (2014) 0.79
Community awareness of stroke in Accra, Ghana. BMC Public Health (2014) 0.78
Cerebral infarction in acute anemia. J Neurol (2010) 0.77
Antibody levels to persistent pathogens and incident stroke in Mexican Americans. PLoS One (2013) 0.77
Mitochondrial Cyclophilin D in Vascular Oxidative Stress and Hypertension. Hypertension (2016) 0.77
Presence and extent of coronary calcified plaque evaluated by coronary computed tomographic angiography are independent predictors of ischemic stroke in patients with suspected coronary artery disease. Int J Cardiovasc Imaging (2015) 0.77
Accuracy of self-perception of cardiovascular risk in the community. J Vasc Interv Neurol (2008) 0.77
Antihypertensive effect of mitochondria-targeted proxyl nitroxides. Redox Biol (2014) 0.77
Risk factors for acute stroke among South Asians compared to other racial/ethnic groups. PLoS One (2014) 0.77
Poor drug adherence and lack of awareness of hypertension among hypertensive stroke patients in Kampala, Uganda: a cross sectional study. BMC Res Notes (2016) 0.76
Risk Factors and Hospitalization Costs of Dementia Patients: Examining Race and Gender Variations. Indian J Community Med (2015) 0.75
Risk factors and subtypes of acute ischemic stroke. A study at King Fahd Hospital of the University. Neurosciences (Riyadh) (2016) 0.75
Migraine: a risk factor for ischemic stroke in young women. Stroke (1997) 0.75
Assessment of demographic and clinical characteristics on functional status and disability of patients with stroke. Neurosciences (Riyadh) (2016) 0.75
Relationship between coffee consumption and stroke risk in Korean population: the Health Examinees (HEXA) Study. Nutr J (2017) 0.75
Forced Expiratory Volume in the First Second and Aldosterone as Mediators of Smoking Effect on Stroke in African Americans: The Jackson Heart Study. J Am Heart Assoc (2016) 0.75
Exercise increases serum endostatin levels in female and male patients with diabetes and controls. Cardiovasc Diabetol (2014) 0.75
Increasing trend of diabetes combined with hypertension or hypercholesterolemia: NHANES data analysis 1999-2012. Sci Rep (2016) 0.75
Is cirrhosis associated with lower odds of ischemic stroke: A nationwide analysis? World J Hepatol (2016) 0.75
Estrogen Receptor (ER)-α36 Is Involved in Estrogen- and Tamoxifen-Induced Neuroprotective Effects in Ischemic Stroke Models. PLoS One (2015) 0.75
Silent new ischemic lesions after index stroke and the risk of future clinical recurrent stroke. Neurology (2015) 0.75
Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project. J Epidemiol (2016) 0.75
Stroke Best Practices: a team approach to evidence-based care. J Natl Med Assoc (2004) 0.75
Risk of Stroke and Post-Stroke Adverse Events in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease. PLoS One (2017) 0.75
Effect of acupuncture on cerebrovascular reserve in patients with acute cerebral infarction: protocol for a randomized controlled pilot study. Trials (2017) 0.75
Three periods of one and a half decade of ischemic stroke susceptibility gene research: lessons we have learned. Genome Med (2010) 0.75
Right atrial diameter and outcome of catheter ablation of atrial fibrillation. J Interv Card Electrophysiol (2017) 0.75
A comparison of carotid surgery in northern Europe and northern Africa. World J Surg (2010) 0.75
Is normal-tension glaucoma a risk factor for stroke?-A 10-year follow-up study. PLoS One (2017) 0.75
Sirt3 Impairment and SOD2 Hyperacetylation in Vascular Oxidative Stress and Hypertension. Circ Res (2017) 0.75
A SNP in 5' untranslated region of CD40 gene is associated with an increased risk of ischemic stroke in a Chinese population: a case-control study. Genet Mol Biol (2017) 0.75
Measuring functional connectivity in stroke: Approaches and considerations. J Cereb Blood Flow Metab (2017) 0.75
Sustained Neurological Recovery After Stroke in Aged Rats Treated With a Novel Prostacyclin Analog. Stroke (2017) 0.75
The Cardiovascular Health Study: design and rationale. Ann Epidemiol (1991) 27.24
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med (1999) 16.30
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Spontaneous intracerebral hemorrhage. N Engl J Med (2001) 8.60
Incidence of and risk factors for atrial fibrillation in older adults. Circulation (1997) 8.18
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke (1999) 7.93
Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke (1996) 7.81
Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol (1993) 7.49
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation (2000) 7.37
Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol (1995) 7.28
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med (2001) 7.07
The ABCs of measuring intracerebral hemorrhage volumes. Stroke (1996) 6.78
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med (1999) 5.01
Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology (2001) 4.78
The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol (2000) 4.77
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation (1993) 4.75
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74
Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation (1994) 4.52
Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol (1998) 4.44
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med (2000) 4.33
Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke (1991) 4.21
Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes (1996) 4.20
Inverse association of dietary fat with development of ischemic stroke in men. JAMA (1998) 4.20
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology (2000) 4.13
Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke (1996) 4.13
Stroke severity in atrial fibrillation. The Framingham Study. Stroke (1996) 4.11
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol (1994) 4.08
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology (2008) 4.07
Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 4.04
A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med (1989) 3.83
Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study. Am J Public Health (1990) 3.82
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Why African Americans may not be participating in clinical trials. J Natl Med Assoc (1996) 3.68
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology (1998) 3.62
Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Intern Med (2000) 3.60
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Morning increase in onset of ischemic stroke. Stroke (1989) 3.52
Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology (2009) 3.45
Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell (2006) 3.44
Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med (1992) 3.38
Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol (1999) 3.36
Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials (1991) 3.30
Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology (2010) 3.27
The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. Ann Epidemiol (1995) 3.24
Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord (2003) 3.23
Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol (1995) 3.19
The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med (1987) 3.17
Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol (1989) 3.13
Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology (2007) 3.12
The Stroke Data Bank: design, methods, and baseline characteristics. Stroke (1988) 3.12
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA (1999) 3.11
Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke (1992) 3.09
A method for using MR to evaluate the effects of cardiovascular disease on the brain: the cardiovascular health study. AJNR Am J Neuroradiol (1994) 3.07
Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology (2004) 2.97
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet (1989) 2.97
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93
Projected costs of ischemic stroke in the United States. Neurology (2006) 2.93
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology (2011) 2.91
The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg (1993) 2.91
Education and change in cognitive function. The Epidemiologic Catchment Area Study. Ann Epidemiol (1995) 2.87
Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke (1995) 2.86
What role do neurologists play in determining the costs and outcomes of stroke patients? Stroke (1996) 2.84
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med (1999) 2.82
Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med (1997) 2.81
Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc (1999) 2.80
Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: the Cardiovascular Health Study. J Am Geriatr Soc (1997) 2.79
Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. Stroke (2000) 2.78
Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med (1992) 2.77
Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol (1998) 2.77
Long-term mortality after intracerebral hemorrhage. Neurology (2006) 2.71
Design of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST). Int J Stroke (2010) 2.71
Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke (2001) 2.71
Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation (1999) 2.71
Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol (1993) 2.67
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology (1992) 2.64
beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program. Stroke (2001) 2.60
Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke (1999) 2.56
Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med (2000) 2.54
Accuracy of hospital discharge abstracts for identifying stroke. Stroke (1994) 2.53
Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) Am J Cardiol (1999) 2.51
Protective effect of fruits and vegetables on development of stroke in men. JAMA (1995) 2.50